Orion Pharma (UK) Limited

Oaklea Court, 22 Park Street, Newbury, Berkshire, RG14 1EA
Telephone: +44 (0)1635 520 300
Fax: +44 (0)1635 580 180
Medical Information e-mail: medicalinformation@orionpharma.com
Out of Hours Telephone: +44 (0)1635 520 300

Summary of Product Characteristics last updated on the eMC: 09/04/2009
SPC Frusene Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/04/2009 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Date of revision of text on the SPC:   01-Jul-2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

None provided
Updated on 22/09/2006 and displayed until 09/04/2009
Reasons for adding or updating:
  • Change to section 8 - MA number
Date of revision of text on the SPC:   07/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

The MA number has been amended
Updated on 13/08/2004 and displayed until 22/09/2006
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
Updated on 16/07/2004 and displayed until 13/08/2004
Reasons for adding or updating:
  • Change to section 4.3 - Contra-indications
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
  • Change to section 4.8 - Undesirable Effects
Updated on 06/09/1999 and displayed until 16/07/2004
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   triamterene
   furosemide